These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6988911)

  • 41. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
    Noguchi M; Tajiri K; Taniya T; Kumaki T; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 May; 90(5):780-5. PubMed ID: 2529423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer.
    Nemoto T; Patel JK; Rosner D; Dao TL; Halvorson H
    J Surg Oncol; 1989 Aug; 41(4):226-9. PubMed ID: 2526907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of hormones on proliferation of ER-positive cells and ER-negative cells of human breast cancer (MCF-7).
    Noguchi M; Tajiri K; Taniya T; Kumaki T; Ashikari A; Miyazaki I
    Oncology; 1990; 47(1):19-24. PubMed ID: 2137212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
    Noguchi S; Yamamoto H; Inaii H; Koyama H
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3555-8. PubMed ID: 2530936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
    Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
    Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
    Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
    Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
    Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.
    Fisher B; Jeong JH; Dignam J; Anderson S; Mamounas E; Wickerham DL; Wolmark N
    J Natl Cancer Inst Monogr; 2001; (30):62-6. PubMed ID: 11773294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):447-54. PubMed ID: 8678496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model.
    De Oliveira Andrade F; Yu W; Zhang X; Carney E; Hu R; Clarke R; FitzGerald K; Hilakivi-Clarke L
    Endocr Relat Cancer; 2019 Mar; 26(3):339-353. PubMed ID: 30640711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
    Nomura Y; Tashiro H; Takaeko F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
    Fernandez MD; Alaghband-Zadeh J; Burn JI
    Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial.
    Gockerman JP; Spremulli EN; Raney M; Logan T
    Cancer Treat Rep; 1986 Oct; 70(10):1199-203. PubMed ID: 3530447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of estrogen receptor associated with an increased response rate to cytotoxic chemotherapy in metastatic breast cancer?
    Lippman ME; Allegra JC
    Recent Results Cancer Res; 1980; 71():155-61. PubMed ID: 7367728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer].
    Takatsuka Y; Yayoi E; Miyauchi K; Aikawa T; Maeura Y; Hirai T; Kotsuma Y
    Gan To Kagaku Ryoho; 1992 May; 19(5):631-6. PubMed ID: 1533755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer.
    Johnston SR; Haynes BP; Sacks NP; McKinna JA; Griggs LJ; Jarman M; Baum M; Smith IE; Dowsett M
    Breast Cancer Res Treat; 1993 Dec; 28(3):241-50. PubMed ID: 8018953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endocrine treatment of advanced breast cancer.
    Maass H; Jonat W
    Recent Results Cancer Res; 1980; 71():102-11. PubMed ID: 6988909
    [No Abstract]   [Full Text] [Related]  

  • 59. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
    Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR
    Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of medroxyprogesterone acetate on bone metabolism in the oophorectomized, tamoxifen-treated rat.
    Isserow JA; Rucinski B; Romero DF; Mann GN; Liu CC; Epstein S
    Endocrinology; 1995 Feb; 136(2):713-9. PubMed ID: 7835304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.